Skip to content Skip to sidebar Skip to footer

Healthcare Stocks Life Sciences Small Caps Stocks Tech Stocks Technology

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Cyclopharm (ASX:CYC) is a rare species - an ASX stock that is approved in the US market. However, its share price has gone in the opposite direction. Cyclopharm has not…

ByNick Sundich

Jul 2024

General Healthcare Stocks

What are the best ASX Health Stocks for FY25? Here are our top 4 picks!

As FY24 has come to an end, we thought we'd list our best ASX Health Stocks for FY25! Traditionally, healthcare stocks are seen as defensive plays in dour markets. This…

ByNick Sundich

Oct 2023

Healthcare Stocks

FDA approval: Here’s how ASX biotechs and medtechs obtain it

Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years to obtain and one that wasn't reached without setbacks along…

ByNick Sundich

Sep 2023

Healthcare Stocks

The 3 best ASX biotech stocks for September!

Here are a trio of companies that we think are the best ASX biotech stocks for September! What are the Best stocks to invest in right now? Check our buy/sell stock…

ByNick Sundich

Feb 2023

Life Sciences

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

In the past year, biotech shares have performed poorly. Why has this been the case and will things be better in 2023? SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!…

ByNick Sundich

Dec 2022

Life Sciences

Which ASX health stocks might get FDA approval in 2023?

It is the dream of many ASX health stocks and their investors for their company's device or drug to be approved by the FDA, the USA's medical regulator. This is…

ByNick Sundich

the Kick-ass Multipurpose WordPress Theme

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

What are the best ASX Health Stocks for FY25? Here are our top 4 picks!

FDA approval: Here’s how ASX biotechs and medtechs obtain it

The 3 best ASX biotech stocks for September!

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

Which ASX health stocks might get FDA approval in 2023?

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here